semaglutide lawsuit texas As of February 21, 2025, the FDA updated its drug shortage list, marking Semaglutide Eye Damage | Ozempic

Last weeks JAMA had two articles on GLP-1 drugs that point to their promise for treatment of diseases beyond the conditions for which they are already approved by the FDA: obesity, diabetes, cardiovascular risk, sleep apnea and metabolic liver disease

That's where functional medicine comes in to help your metabolism heal itself. Key Questions That Should Be Asked For both patient and clinician , these are the crucial questions to explore before, during, and after GLP-1 therapy: 1

This is a process where your doctor has to submit extensive paperwork to the insurance company to justify why you need this specific medication

Running them together covers both the local and whole-body sides of repair